August 16, 2016 — Cardiovascular Systems Inc. (CSI) released procedural and 30-day results from its LIBERTY 360° study ...
May 6, 2016 — Cardiovascular Systems Inc. shared three-year results from its pivotal ORBIT II study in a featured ...
It is estimated that more than 10 million people in the United States are affected by peripheral arterial disease (PAD) ...
November 3, 2015 — Cardiovascular Systems Inc. (CSI) announced last week that the first two patients have been enrolled ...
July 22, 2015 — Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) ...
May 12, 2015 — Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s ...
April 24, 2015 — Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) ...
Nov. 6, 2014 — Cardiovascular Systems Inc. received the CE Mark for its Stealth 360º Orbital Atherectomy System (OAS) ...
October 30, 2014 — Cardiovascular Systems Inc. announced that the first seven patients in Japan have been enrolled in ...
Cardiovascular Systems is recalling certain lots of the Diamondback 360 Peripheral Orbital Atherectomy System, because ...